• * at the end of a keyword allows wildcard searches
  • " quotes can be used for searching phrases
  • + represents an AND search (default)
  • | represents an OR search
  • - represents a NOT operation
  • ( and ) implies priority
  • ~N after a word specifies the desired edit distance (fuzziness)
  • ~N after a phrase specifies the desired slop amount
  • 1 (current)
Found 2 result(s)
Country
The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information. The latest release of DrugBank (version 5.1.1, released 2018-07-03) contains 11,881 drug entries including 2,526 approved small molecule drugs, 1,184 approved biotech (protein/peptide) drugs, 129 nutraceuticals and over 5,751 experimental drugs. Additionally, 5,132 non-redundant protein (i.e. drug target/enzyme/transporter/carrier) sequences are linked to these drug entries. Each DrugCard entry contains more than 200 data fields with half of the information being devoted to drug/chemical data and the other half devoted to drug target or protein data.
GRID-Geneva is a unique platform providing analyses and solutions for a wide range of environmental issues. GRID-Geneva serves primarily the needs of its three institutional partners - UNEP, the Swiss Federal Office for the Environment (FOEN) and the University of Geneva (UniGe) - which are linked by an ongoing, multi-year “Partnership Agreement”, along with other local-to-global stakeholders. GRID-Geneva is also a bilingual English and French centre and the key francophone link within the global GRID network of centres. GRID-Geneva is a key centre of geo-spatial know-how, with strengths in GIS, IP/remote sensing and statistical analyses, integrated through modern spatial data infrastructures and web applications. Working at the interface between scientific information and policy/decision-making, GRID-Geneva also helps to develop capacities in these fields of expertise among target audiences, countries and other groups.